News24.com | Alzheimer's drug succeeds in slowing cognitive decline, makers Eisai and Biogen say

Eisai Co Ltd and Biogen Inc on Tuesday said their experimental Alzheimer's drug significantly slowed cognitive and functional decline in a large trial of patients in the early stages of the disease, marking a rare win in a field littered with failed drugs.